← Back to Clinical Trials
Recruiting NCT07024420

NCT07024420 Sigh Ventilation in Cardiac Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07024420
Status Recruiting
Phase
Sponsor Zhongda Hospital
Condition Postoperative Pulmonary Complications (PPCs)
Study Type INTERVENTIONAL
Enrollment 686 participants
Start Date 2025-10-09
Primary Completion 2027-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Sigh BreathsLow Tidal VolumeModerate PEEP

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 686 participants in total. It began in 2025-10-09 with a primary completion date of 2027-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this trial is to investigate whether sigh ventilation strategy, combining sigh breaths, low tidal volume, and moderate PEEP levels, protects against major pulmonary complications within the first 7 postoperative days after cardiac surgery, as compared with conventional ventilation strategy with low tidal volume, and moderate PEEP levels.

Eligibility Criteria

Inclusion Criteria: * 18 years of age or older; * Elective cardiac surgery with cardiopulmonary bypass, aortic clamp and cardioplegia; * Written informed consent is obtained from patients and/or their legal representatives. Exclusion Criteria: * Emergence surgery; * Left ventricular assist device implantation; * Planned thoracotomy with one lung ventilation; * Undergo concurrent surgical procedures outside cardiology; * Neuromuscular illness; * Mechanical ventilation within the last 2 weeks before surgery, include CPAP and NIV; * Preoperative shock; * Preoperative Hypoxemia (PaO2\<60mmHg OR SpO2\<90% on ambient air); * Preoperative left ventricular ejection fraction \< 40%; * Systolic pulmonary artery pressure \> 50 mmHg.

Contact & Investigator

Central Contact

Zhichang Wang

✉ wang15zc@163.com

📞 +8618255127433

Frequently Asked Questions

Who can join the NCT07024420 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Postoperative Pulmonary Complications (PPCs). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07024420 currently recruiting?

Yes, NCT07024420 is actively recruiting participants. Contact the research team at wang15zc@163.com for enrollment information.

Where is the NCT07024420 trial being conducted?

This trial is being conducted at Nanjing, China.

Who is sponsoring the NCT07024420 clinical trial?

NCT07024420 is sponsored by Zhongda Hospital. The trial plans to enroll 686 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology